BackSoleno Therapeutics Overview

Soleno Therapeutics Net Income

Profitability analysis for SLNO.

Quarterly Net Income

$31.38M
171.68% YoY

As of Mar 2026

Annual Net Income (TTM)

$96.04M
148.45% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...